Departamento de Cirugía Oral y Maxilofacial, Facultad de Odontología, Universidad Autónoma de Baja California, Mexicali, BC, México.
Consulta privada, Tepic, Nayarit, México.
Clin Oral Investig. 2021 Dec;25(12):6779-6790. doi: 10.1007/s00784-021-03965-x. Epub 2021 Apr 28.
The aim of this meta-analysis was to assess the clinical efficacy and safety profile of ropivacaine in comparison with other dental anesthetics in different clinical conditions. MATERIALS AND METHODS: This meta-analysis was registered in the National Institute for Health Research PROSPERO (ID: CRD42020205580). PubMed and Scholar Google were consulted to identify clinical trials using ropivacaine in comparison with other local anesthetic drugs for any dental procedure. Articles comparing ropivacaine and other dental anesthetics were assessed with the Cochrane Collaboration's risk of bias tool. Data from reports without a high risk of bias were extracted (anesthetic and adverse effects) and analyzed using the Review Manager Software 5.3. for Windows and the Risk Reduction Calculator.
Ropivacaine produces a longer anesthetic time when compared with lidocaine/adrenaline (n = 260; p = 0.00001) and similar anesthesia than bupivacaine (n = 190).
Data of this study indicate that ropivacaine infiltration produces a longer anesthetic time when compared with lidocaine and articaine but not when compared to bupivacaine in dental procedures.
Ropivacaine was more effective than lidocaine for dental anesthesia. For this reason, the manufacture of a ropivacaine dental cartridge with a suitable concentration could be an important advancement for clinical practice.
本荟萃分析旨在评估罗哌卡因与其他牙科麻醉剂在不同临床情况下的临床疗效和安全性。
本荟萃分析已在英国国家卫生研究院 PROSPERO(注册号:CRD42020205580)注册。通过检索 PubMed 和 Scholar Google,确定了使用罗哌卡因与其他局部麻醉药物进行任何牙科手术的临床试验。使用 Cochrane 协作风险偏倚工具评估比较罗哌卡因和其他牙科麻醉剂的文章。从报告中提取无高偏倚风险的数据(麻醉和不良反应),并使用 Review Manager Software 5.3 for Windows 和风险降低计算器进行分析。
与利多卡因/肾上腺素(n = 260;p = 0.00001)相比,罗哌卡因产生的麻醉时间更长,与布比卡因(n = 190)相比,麻醉效果相似。
本研究数据表明,与利多卡因和阿替卡因相比,罗哌卡因浸润在牙科手术中产生的麻醉时间更长,但与布比卡因相比则不然。
罗哌卡因比利多卡因更适用于牙科麻醉。因此,制造一种适合浓度的罗哌卡因牙科注射器可能是临床实践的重要进展。